Co-Diagnostics, Inc. Annual Operating Income (Loss) in USD from 2016 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Co-Diagnostics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2024.
  • Co-Diagnostics, Inc. Operating Income (Loss) for the quarter ending June 30, 2025 was -$8.06M, a 4.92% decline year-over-year.
  • Co-Diagnostics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2025 was -$38.8M, a 0.13% decline year-over-year.
  • Co-Diagnostics, Inc. annual Operating Income (Loss) for 2024 was -$40.1M, a 6.15% increase from 2023.
  • Co-Diagnostics, Inc. annual Operating Income (Loss) for 2023 was -$42.7M, a 58.3% decline from 2022.
  • Co-Diagnostics, Inc. annual Operating Income (Loss) for 2022 was -$27M, a 159% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$40.1M +$2.62M +6.15% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-27
2023 -$42.7M -$15.7M -58.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-27
2022 -$27M -$73M -159% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $46.1M +$4.37M +10.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $41.7M +$47.6M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 -$5.89M +$224K +3.66% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 -$6.12M -$1.55M -34% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 -$4.56M -$2.88M -170% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 -$1.69M Jan 1, 2016 Dec 31, 2016 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.